Since time immemorial, to look young and beautiful has always been an important consideration for human beings. In this pursuit, the modern era of scientific treatments for aesthetics and body rejuvenation is documented to have begun in the late 1800s.
The early technique, known as soft-tissue augmentation, involved the use of transplanted fat to repair cosmetic deformities. Since then, physicians have been on a consistent quest to find the ideal filler substance for such purposes. Moreover, ongoing research and technological advancements have paved the way for noninvasive procedures to take over from traditionally performed face-lift surgeries.
Hence, driven by patient demand for facial beauty treatments, combined with increasing preference for non-surgical cosmetic procedures, the demand for facial aesthetic procedures is set for noteworthy growth in the foreseeable future. Facial injectables, which constitute an important segment of facial aesthetic treatments, will exhibit notable demand, with the facial injectables market expected to grow at an impressive 14.6 % CAGR from 2014 to 2020, as projected by Transparency Market Research.
Browse Market Research Report of Facial Injectables Market: http://www.transparencymarketresearch.com/facial-injectables-market.html
What are Dermal/Facial Fillers Used for?
Dermal fillers such as collagen, botulinum toxin, particle and polymer fillers, and hyaluronic acid are meant to reduce facial lines and to give plump to the face. These are injectable compounds that can be safely injected below the skin surface to treat skin depressions. The use of these compounds helps raise the skin level, add volume to it, and restore a supple, youthful skin in minutes.
With aging, facial tissue tends to lose subcutaneous fat. As a result, facial muscles come in close contact with the skin surface, leading to crow’s feet and smile lines to be visible. In addition, with aging, facial skin also stretches to some extent, augmenting the facial volume loss.
Some of the processes dermal fillers are suited for are plumping thin lips, diminishing facial creases and wrinkles, improving shallow contours, and enhancing the look of recessed scars. Dermal fillers work on early signs of aging or as an additional component of facial rejuvenation surgery.
Browse Market Research Press Release of Facial Injectables Market: http://www.transparencymarketresearch.com/pressrelease/facial-injectables-market.htm
New Product Launch of Facial Injectables Raises Competitive Pressure in North America
Presently, North America dominates the global facial injectables market. The region accounted for 40.9% of the global market in 2013. The numerous reasons for the large market share of the region are its highly advanced healthcare infrastructure, high healthcare spending by both patients and the government, reimbursement coverage, increasing consumer awareness about beauty products and the advantages of facial injectables, and a large geriatric population base, among others.
However, the 2008 economic recession led to a large slump in the facial injectables market in the region. Thereafter, with overall economic recovery, the facial injectables market has experienced notable growth. According to analysts’ estimates, by 2016, the sales of dermal filler products and botulinum toxin (BTX) will experience high growth due to continued demand for aesthetic procedures.
In 2011, Merz Pharmaceuticals launched two new products, Belotero and Xeomin, which are a dermal filler and BTX, respectively. The availability of a large product range for both physicians and patients to choose from has altered the competitive landscape of the North America facial injectables market. New product launches, combined with competitive pricing pressure, have been the reason for the strong growth of the facial injectables market in North America.
Nevertheless, increasing patient awareness about aesthetics and the continual demand for facial injectable procedures has driven unit sales, which in turn has facilitated the expansion of the markets for both dermal fillers and BTX in the region.